Logo image of EMO.CA

EMERITA RESOURCES CORP (EMO.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:EMO - CA29102L4064 - Common Stock

0.54 CAD
-0.04 (-6.9%)
Last: 12/29/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, EMO scores 2 out of 10 in our fundamental rating. EMO was compared to 804 industry peers in the Metals & Mining industry. EMO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. EMO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year EMO has reported negative net income.
EMO had a negative operating cash flow in the past year.
EMO had negative earnings in each of the past 5 years.
In the past 5 years EMO always reported negative operating cash flow.
EMO.CA Yearly Net Income VS EBIT VS OCF VS FCFEMO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

EMO's Return On Assets of -25.73% is in line compared to the rest of the industry. EMO outperforms 46.14% of its industry peers.
EMO's Return On Equity of -30.48% is in line compared to the rest of the industry. EMO outperforms 50.25% of its industry peers.
Industry RankSector Rank
ROA -25.73%
ROE -30.48%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EMO.CA Yearly ROA, ROE, ROICEMO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EMO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMO.CA Yearly Profit, Operating, Gross MarginsEMO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

5

2. Health

2.1 Basic Checks

The number of shares outstanding for EMO has been increased compared to 5 years ago.
EMO.CA Yearly Shares OutstandingEMO.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2024 50M 100M 150M 200M
EMO.CA Yearly Total Debt VS Total AssetsEMO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 10.88 indicates that EMO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 10.88, EMO is in the better half of the industry, outperforming 65.30% of the companies in the same industry.
A Debt/Equity ratio of 0.16 indicates that EMO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.16, EMO is doing worse than 66.79% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 10.88
ROIC/WACCN/A
WACCN/A
EMO.CA Yearly LT Debt VS Equity VS FCFEMO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 7.41 indicates that EMO has no problem at all paying its short term obligations.
EMO has a better Current ratio (7.41) than 79.85% of its industry peers.
A Quick Ratio of 7.41 indicates that EMO has no problem at all paying its short term obligations.
EMO's Quick ratio of 7.41 is amongst the best of the industry. EMO outperforms 80.35% of its industry peers.
Industry RankSector Rank
Current Ratio 7.41
Quick Ratio 7.41
EMO.CA Yearly Current Assets VS Current LiabilitesEMO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2024 5M 10M 15M 20M 25M

1

3. Growth

3.1 Past

EMO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.59%, which is quite good.
EPS 1Y (TTM)19.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.62%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

EMO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 90.42% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5Y90.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMO.CA Yearly Revenue VS EstimatesEMO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 200M 400M 600M 800M
EMO.CA Yearly EPS VS EstimatesEMO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2028 2029 0.2 0.4 0.6 0.8 1

1

4. Valuation

4.1 Price/Earnings Ratio

EMO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EMO.CA Price Earnings VS Forward Price EarningsEMO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EMO.CA Per share dataEMO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1

4.3 Compensation for Growth

EMO's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y25.99%

0

5. Dividend

5.1 Amount

EMO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

EMERITA RESOURCES CORP

TSX-V:EMO (12/29/2025, 7:00:00 PM)

0.54

-0.04 (-6.9%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)01-23 2026-01-23
Inst Owners2.05%
Inst Owner ChangeN/A
Ins Owners5.02%
Ins Owner ChangeN/A
Market Cap156.31M
Revenue(TTM)N/A
Net Income(TTM)-12.88M
Analysts86
Price Target2.04 (277.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-29.2%
PT rev (3m)-19.19%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.7
P/tB 3.7
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.15
TBVpS0.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -25.73%
ROE -30.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12444.7%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.41
Quick Ratio 7.41
Altman-Z 10.88
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)855.19%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.62%
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5Y90.42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y35.55%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y77.39%
OCF growth 3YN/A
OCF growth 5YN/A

EMERITA RESOURCES CORP / EMO.CA FAQ

What is the fundamental rating for EMO stock?

ChartMill assigns a fundamental rating of 2 / 10 to EMO.CA.


What is the valuation status for EMO stock?

ChartMill assigns a valuation rating of 1 / 10 to EMERITA RESOURCES CORP (EMO.CA). This can be considered as Overvalued.


How profitable is EMERITA RESOURCES CORP (EMO.CA) stock?

EMERITA RESOURCES CORP (EMO.CA) has a profitability rating of 1 / 10.


What is the earnings growth outlook for EMERITA RESOURCES CORP?

The Earnings per Share (EPS) of EMERITA RESOURCES CORP (EMO.CA) is expected to grow by 100% in the next year.